|
[1] LEE GR. The balance of Th17 versus Treg cells in autoimmunity[J]. Int J Mol Sci,2018,19(3):730.
|
|
[2] HARRINGTON LE,HATTON RD,MANGAN PR,et al. Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol,2005,6(11):1123-1132.
|
|
[3] PARK H,LI Z,YANG XO,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J]. Nat Immunol,2005,6(11):1133-1141.
|
|
[4] BERINGER A,MIOSSEC P. IL-17 and IL-17-producing cells and liver diseases,with focus on autoimmune liver diseases[J]. Autoimmun Rev,2018,17(12):1176-1185.
|
|
[5] BROCKMANN L,GIANNOU AD,GAGLIANI N,et al. Regulation of T(H)17 cells and associated cytokines in wound healing,tissue regeneration,and carcinogenesis[J]. Int J Mol Sci,2017,18(5):16.
|
|
[6] DUDAKOV JA,HANASH AM,VAN DEN BRINK MRM. Interleukin-22:Immunobiology and pathology[M]//LITTMAN DR,YOKOYAMA WM. Annual Review of Immunology Vol 33.Palo Alto; Annual Reviews. 2015:747-785.
|
|
[7] EYERICH K,DIMARTINO V,CAVANI A. IL-17 and IL-22 in immunity:Driving protection and pathology[J]. Eur J Immunol,2017,47(4):607-614.
|
|
[8] BAO S,ZHAO Q,ZHENG J,et al. Interleukin-23 mediates the pathogenesis of LPS/Gal N-induced liver injury in mice[J]. Int Immunopharmacol,2017,46:97-104.
|
|
[9] WEI CB,TAO K,JIANG R,et al. Quercetin protects mouse liver against triptolide-induced hepatic injury by restoring Th17/Treg balance through Tim-3 and TLR4-MyD88-NF-κB pathway[J]. Int Immunopharmacol,2017,53:73-82.
|
|
[10] WAN Z,ZHOU Z,LIU Y,et al. Regulatory T cells and T helper 17 cells in viral infection[J]. Scand J Immunol,2020,91(5):e12873.
|
|
[11] PAQUISSI FC. Immunity and fibrogenesis:The role of Th17/IL-17 axis in HBV and HCV-induced chronic hepatitis and progression to cirrhosis[J]. Front Immunol,2017,8:1195.
|
|
[12] LI X,SU Y,HUA X,et al. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis[J]. J Transl Med,2017,15(1):75.
|
|
[13] LI K,LIU H,GUO T. Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients[J]. Clin Res Hepatol Gastroenterol,2017,41(4):399-407.
|
|
[14] HU Z,LUO D,WANG D,et al. IL-17 activates the IL-6/STAT3 signal pathway in the proliferation of hepatitis B virusrelated hepatocellular carcinoma[J]. Cell Physiol Biochem,2017,43(6):2379-2390.
|
|
[15] TIAN CH,DAI J,ZHANG W,et al. Expression of IL-17 and its gene promoter methylation status are associated with the progression of chronic hepatitis B virus infection[J]. Medicine(Baltimore),2019,98(23):e15924.
|
|
[16] CACHEM F,DIAS AS,MONTEIRO C,et al. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C[J]. Immunology,2017,151(2):167-176.
|
|
[17] NYIRENDA MH,SANVITO L,DARLINGTON PJ,et al. TLR2stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function[J]. J Immunol,2011,187(5):2278-2290.
|
|
[18] LIU X,GUAN JH,JIANG BC,et al. Toll-like receptor 2 modulates the balance of regulatory T cells and T helper 17 cells in chronic hepatitis C[J]. Viral Immunol,2016,29(6):322-331.
|
|
[19] QIN L,ZHOU YC,WU HJ,et al. Notch signaling modulates the balance of regulatory T cells and T helper 17 cells in patients with chronic hepatitis C[J]. DNA Cell Biol,2017,36(4):311-320.
|
|
[20] HE B,WU L,XIE W,et al. The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice[J]. BMC Immunol,2017,18(1):33.
|
|
[21] HAUSE RJ,PRITCHARD CC,SHENDURE J,et al. Corrigendum:Classification and characterization of microsatellite instability across 18 cancer types[J]. Nat Med,2017,23(10):1241.
|
|
[22] LIU Y,YAN W,YUAN W,et al. Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis[J]. Clin Immunol,2019,198:79-88.
|
|
[23] XIA G,WU S,WANG X,et al. Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation[J]. Can J Physiol Pharmacol,2018,96(12):1293-1300.
|
|
[24] HU ED,CHEN DZ,WU JL,et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier[J]. Cell Immunol,2018,328:24-32.
|
|
[25] CICHOZ·-LACH H,GRYWALSKA E,MICHALAK A,et al. Deviations in peripheral blood cell populations are associated with the stage of primary biliary cholangitis and presence of itching[J].Arch Immunol Ther Exp(Warsz),2018,66(6):443-452.
|
|
[26] SUN Q,WANG Q,FENG N,et al. The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis[J]. Ann Transl Med,2019,7(16):389.
|
|
[27] SONG Y,YANG H,JIANG K,et al. miR-181a regulates Th17cells distribution via up-regulated BCL-2 in primary biliary cholangitis[J]. Int Immunopharmacol,2018,64:386-393.
|
DownLoad: